Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.150
+0.030 (2.68%)
At close: Feb 6, 2026, 4:00 PM EST
1.200
+0.050 (4.35%)
After-hours: Feb 6, 2026, 7:55 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $39.54 million as of February 6, 2026. Its market cap has decreased by -72.02% in one year.
Market Cap
39.54M
Enterprise Value
32.30M
1-Year Change
-72.02%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $39.54M, a decrease of -80.92%. That is a compound annual growth rate of -56.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 39.54M | -13.53% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 41.31M |
| ABVC BioPharma | 41.01M |
| Galecto | 40.35M |
| INmune Bio | 40.14M |
| Lisata Therapeutics | 40.05M |
| PDS Biotechnology | 39.13M |
| Lite Strategy | 38.98M |
| NextCure | 38.91M |